JP2022515487A5 - - Google Patents
Info
- Publication number
- JP2022515487A5 JP2022515487A5 JP2021537771A JP2021537771A JP2022515487A5 JP 2022515487 A5 JP2022515487 A5 JP 2022515487A5 JP 2021537771 A JP2021537771 A JP 2021537771A JP 2021537771 A JP2021537771 A JP 2021537771A JP 2022515487 A5 JP2022515487 A5 JP 2022515487A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequences
- sequence numbers
- cdr3
- cdr1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024103100A JP7724332B2 (ja) | 2018-12-28 | 2024-06-26 | クローディン18.2結合部分およびその利用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2018125052 | 2018-12-28 | ||
| CNPCT/CN2018/125052 | 2018-12-28 | ||
| CNPCT/CN2019/095827 | 2019-07-12 | ||
| CN2019095827 | 2019-07-12 | ||
| PCT/CN2019/129017 WO2020135674A1 (en) | 2018-12-28 | 2019-12-27 | Claudin18.2 binding moieties and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024103100A Division JP7724332B2 (ja) | 2018-12-28 | 2024-06-26 | クローディン18.2結合部分およびその利用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022515487A JP2022515487A (ja) | 2022-02-18 |
| JP2022515487A5 true JP2022515487A5 (cg-RX-API-DMAC7.html) | 2022-11-24 |
Family
ID=71127698
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021537771A Pending JP2022515487A (ja) | 2018-12-28 | 2019-12-27 | クローディン18.2結合部分およびその利用 |
| JP2024103100A Active JP7724332B2 (ja) | 2018-12-28 | 2024-06-26 | クローディン18.2結合部分およびその利用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024103100A Active JP7724332B2 (ja) | 2018-12-28 | 2024-06-26 | クローディン18.2結合部分およびその利用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12258418B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3902839A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2022515487A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210110339A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113227146B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019415848B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021012608A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3125193A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL284393A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021007939A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202106534RA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020135674A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021023024A2 (pt) * | 2019-05-16 | 2022-01-25 | Qilu Pharmaceutical Co Ltd | Anticorpo contra claudina 18a2 e uso do mesmo |
| AU2020378502A1 (en) | 2019-11-05 | 2022-06-16 | LaNova Medicines Limited | Antibody-drug conjugates targeting claudin 18.2 |
| CN114829408B (zh) | 2019-12-20 | 2024-01-26 | 山东博安生物技术股份有限公司 | 用于免疫治疗的t细胞双特异性抗体生产中的优化抗cd3臂 |
| CN113637082A (zh) * | 2020-04-27 | 2021-11-12 | 启愈生物技术(上海)有限公司 | 一种靶向人claudin和人PDL1蛋白的双特异抗体及其应用 |
| CN115698072B (zh) | 2020-07-01 | 2023-07-04 | 山东博安生物技术股份有限公司 | 抗gpc3抗体,抗gpc3嵌合抗原受体和gpc3/cd3双特异性抗体 |
| CN111808194B (zh) * | 2020-07-13 | 2021-04-20 | 北京凯因科技股份有限公司 | 一种结合密蛋白的用于治疗癌症的人源化抗体 |
| WO2022063272A1 (en) * | 2020-09-28 | 2022-03-31 | Elpiscience (Suzhou) Biopharma, Ltd. | Novel anti-claudin18 antibodies |
| TW202233248A (zh) | 2020-11-08 | 2022-09-01 | 美商西健公司 | 組合療法 |
| KR20230113578A (ko) * | 2020-11-27 | 2023-07-31 | 선샤인 레이크 파르마 컴퍼니 리미티드 | Cldn18.2 항체 및 그의 용도 |
| CN114539402B (zh) * | 2020-11-27 | 2025-06-13 | 南京北恒生物科技有限公司 | 靶向Claudin18.2的抗体及其用途 |
| WO2022122709A1 (en) | 2020-12-07 | 2022-06-16 | Sotio Biotech A.S. | Antibody-drug conjugates based on humanized cldn18.2 antibodies |
| KR20230124037A (ko) | 2020-12-23 | 2023-08-24 | 소티오 바이오테크 에이.에스. | 종양 특이적 claudin 18.2 항체-약물 접합체 |
| CN113321730B (zh) * | 2021-01-11 | 2023-10-10 | 上海莱馥医疗科技有限公司 | Cldn18.2抗体及其应用 |
| CN116940598A (zh) * | 2021-02-08 | 2023-10-24 | 山东博安生物技术股份有限公司 | 用于治疗表达cldn18.2的实体瘤的cldn18.2/cd3双特异性抗体 |
| CN115109154A (zh) * | 2021-03-17 | 2022-09-27 | 三优生物医药(上海)有限公司 | 一种靶向cldn18.2的抗体或其抗原结合片段及其应用 |
| WO2022206975A1 (zh) * | 2021-04-02 | 2022-10-06 | 原启生物科技(上海)有限责任公司 | Cldn18.2抗原结合蛋白及其用途 |
| EP4335873A4 (en) * | 2021-05-08 | 2025-03-19 | RemeGen Co., Ltd. | ANTI-CLAUDIN 18.2 ANTIBODY AND ANTIBODY-DRUG CONJUGATE THEREOF |
| WO2023167564A1 (ko) | 2022-03-04 | 2023-09-07 | 앱티스 주식회사 | 티올 반응성 에디티브를 이용한 항체-약물 컨쥬게이트의 제조 수율을 높이는 방법 |
| AU2023371764A1 (en) | 2022-11-01 | 2025-05-15 | AbTis Co., Ltd. | Compound comprising fc-binding unit, and conjugate prepared using same |
| EP4653017A1 (en) | 2023-01-18 | 2025-11-26 | Tyligand Bioscience (Shanghai) Limited | Antibody-drug conjugate and use thereof |
| CN116284224B (zh) * | 2023-05-12 | 2023-07-25 | 中国农业大学 | 一种结合Claudin 18.2的环肽及其应用 |
| WO2025038602A1 (en) * | 2023-08-14 | 2025-02-20 | Ginkgo Bioworks, Inc. | Immune cell stimulatory sequences |
| CN121969385A (zh) | 2023-09-11 | 2026-05-01 | 丹娜-法伯癌症研究院 | 含有il-2变体以增强car t细胞的功能性的car-衔接子 |
| WO2025072299A1 (en) * | 2023-09-25 | 2025-04-03 | Duke University | Compositions comprising hiv envelopes to induce hiv-1 antibodies |
| WO2025148868A1 (zh) | 2024-01-08 | 2025-07-17 | 泰励生物科技(上海)有限公司 | 一种抗体偶联药物及其用途 |
| CN120829517A (zh) * | 2024-04-22 | 2025-10-24 | 鲁南新时代生物技术有限公司 | 抗cldn18.2/cd3双特异性抗体及用途 |
| WO2025251228A1 (en) | 2024-06-05 | 2025-12-11 | Nuwacell Biotechnologies Co., Ltd. | Cldn18.2-targeting chimeric antigen receptor and engineered cell |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1790664A1 (en) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against claudin-18 for treatment of cancer |
| EP1997832A1 (en) * | 2007-05-29 | 2008-12-03 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against Claudin-18 for treatment of cancer |
| WO2013174403A1 (en) * | 2012-05-23 | 2013-11-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
| WO2013174404A1 (en) * | 2012-05-23 | 2013-11-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
| WO2014127785A1 (en) | 2013-02-20 | 2014-08-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
| CN120329449A (zh) * | 2014-07-17 | 2025-07-18 | 恺兴生命科技(上海)有限公司 | 靶向cld18a2的t淋巴细胞及其制备方法和应用 |
| WO2016165762A1 (en) | 2015-04-15 | 2016-10-20 | Ganymed Pharmaceuticals Ag | Drug conjugates comprising antibodies against claudin 18.2 |
| WO2016180468A1 (en) * | 2015-05-11 | 2016-11-17 | Biontech Cell & Gene Therapies Gmbh | Claudin-18.2-specific immunoreceptors and t cell epitopes |
| WO2018006882A1 (zh) * | 2016-07-08 | 2018-01-11 | 科济生物医药(上海)有限公司 | 抗密蛋白18a2的抗体及其应用 |
| MX2020009326A (es) * | 2018-03-08 | 2020-10-08 | Phanes Therapeutics Inc | Anticuerpos anti-claudina 18.2 y usos de los mismos. |
| CN116178554B (zh) * | 2018-05-18 | 2025-09-09 | 礼新医药科技(上海)有限公司 | 抗密蛋白18.2抗体及其用途 |
| JP7840511B2 (ja) * | 2019-02-01 | 2026-04-06 | 石▲薬▼集▲団▼巨石生物制▲薬▼有限公司 | 抗クローディン18抗体及びそれらの使用の方法 |
| CN114630840B (zh) * | 2019-08-20 | 2024-08-02 | 苏州创胜医药集团有限公司 | 新型抗cldn18.2抗体 |
-
2019
- 2019-12-27 MX MX2021007939A patent/MX2021007939A/es unknown
- 2019-12-27 EP EP19906510.3A patent/EP3902839A4/en active Pending
- 2019-12-27 AU AU2019415848A patent/AU2019415848B2/en active Active
- 2019-12-27 US US17/419,203 patent/US12258418B2/en active Active
- 2019-12-27 JP JP2021537771A patent/JP2022515487A/ja active Pending
- 2019-12-27 WO PCT/CN2019/129017 patent/WO2020135674A1/en not_active Ceased
- 2019-12-27 KR KR1020217023724A patent/KR20210110339A/ko not_active Ceased
- 2019-12-27 BR BR112021012608-2A patent/BR112021012608A2/pt unknown
- 2019-12-27 CN CN201980085449.3A patent/CN113227146B/zh active Active
- 2019-12-27 SG SG11202106534RA patent/SG11202106534RA/en unknown
- 2019-12-27 CA CA3125193A patent/CA3125193A1/en active Pending
-
2021
- 2021-06-27 IL IL284393A patent/IL284393A/en unknown
-
2024
- 2024-06-26 JP JP2024103100A patent/JP7724332B2/ja active Active